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List of abbreviations: 
ACR  Acute Cellular Rejection 
aSMA  alpha Smooth Muscle Actin 
BEC  Biliary epithelial cells 
DAPI   4′,6-diamidino-2-phenylindole 
cDNA  complementary DNA 
DMEM   Dulbecco modified Eagle medium 
ECM  extracellular matrix 
ECL  enhanced Chemiluminescence 
H2O2  Hydrogen peroxide 
HRP  horseradish peroxidase 
HSC  Hepatic stellate cells 
HSA  human serum albumin 
FITC  fluorescein isothiocyanate 
GAPDH  glyceraldehyde-3-phosphate 
LAP  Latency Associated Peptides  
LSCM  laser-scanning confocal microscope  
PAGE  polyacrylamide gel electrophoresis 
PCR  polymerase chain reaction 
PVDF  polyvinylidene diflouride 
R  correlation coefficient 
ROS  reactive oxygen species 
SASP  Senescence associated secretory phenotype 
SDS  Sodium-dodecyl sulphate 
TBS  triethanolamine-buffered saline 
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Abstract 
Biliary epithelial cells (BEC) are important targets in some liver diseases, including acute allograft 
rejection. Although some injured BEC die, many can survive in function compromised states of 
senescence or phenotypic de-differentiation. This study was performed to examine changes in the 
phenotype of BEC during acute liver allograft rejection and the mechanism driving these changes. 
Liver allograft sections showed a positive correlation (p<0.0013) between increasing T-Cell mediated 
acute rejection and the number of BEC expressing the senescence marker p21
WAF1/Cip
 or the 
mesenchymal marker S100A4.  This was modelled in vitro by examination of primary or immortalised 
BEC after acute oxidative stress. During the first 48 hours, the expression of p21
WAF1/Cip
 was increased 
transiently before returning to baseline. After this time BEC showed increased expression of 
mesenchymal proteins with a decrease in epithelial markers. Analysis of TGF-β expression at mRNA 
and protein levels also showed a rapid increase in TGF-β2 (p<0.006) following oxidative stress. The 
epithelial de-differentiation observed in vitro was abrogated by pharmacological blockade of the 
ALK-5 component of the TGF-β receptor. These data suggest that stress induced production of TGF-
β2 by BEC can modify liver allograft function by enhancing the de-differentiation of local epithelial 
cells.   
 
Key words: Liver, Epithelial de-differentiation, Biliary disease, Allograft rejection 
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Introduction 
The rate of acute cellular rejection in liver allografts has fallen from 60-70% to 10-20% of graft 
recipients and classical ductopaenic rejection has all but disappeared from clinical practice(1). 
However, this reduction has been accompanied by an increase in factors limiting the quality and 
length of life of liver transplant recipients (1-3). There are significant sequelae associated with the 
administration of immunosuppressive agents, stimulating interest in regimes designed to induce 
tolerance to liver grafts and the ability to maintain grafts with minimal or no immunosuppression(4). 
The limited evidence available also points to increased fibrosis in patients classed as tolerant, with 
no evidence of either acute or chronic rejection (4).  There is also interest in other phenomena 
associated with graft immune responses, such as non-classical antibody-mediated rejection and late 
acute cellular rejection(5, 6) 
While fibrosis is arguably a reversible endpoint, there has been little study of the factors determining 
transition from acute to chronic disease. Unlike other transplanted organs, there is evidence that 
patients suffering an episode of acute liver allograft rejection have a favourable outcome in terms of 
survival with a functioning graft(7), raising the possibility that acute rejection can have beneficial 
effects on the allograft immune infiltrate. Effects of biliary injury in this setting have not been 
studied; however, there has been recent interest in the response of the biliary epithelium during the 
development of ductopaenic liver disease, including chronic rejection(8-10). Lethally injured cells 
typically undergo either necrosis or apoptosis. However, sub-lethal injury can lead to a number of 
conserved processes including senescence(10) or autophagy(11). Cellular senescence is defined as 
loss of the ability to divide and can be induced by replication (exhaustive or replicative senescence) 
or toxic effects, for example from oncogenes or chemokines, and is well defined in chronic 
ductopaenic rejection(12). (12). In practical terms, defining senescence relies on the detection of 
phenotypic markers as it is not possible to follow the life cycle of cells in vivo. The functional 
definition of senescence could therefore be described as cells exhibiting markers, at the time of 
sampling, which indicate further division is unlikely.  There are no reports describing senescence in 
acute cellular rejection of liver allografts. 
Nakanuma et al(10, 13) have investigated the effect of senescence on biliary epithelial cells (BEC) in 
chronic biliary disease, demonstrating a correlation between number of senescent BEC and the 
progression of a number of diseases in human biopsies (8, 10, 13). In replicating the biopsy features 
in vitro, Sasaki et al. (14) used oxidative stress to induce murine biliary epithelial senescence.  
Exposure to hydrogen peroxide replicated the cell expression of the senescence marker p21
WAF1/Cip1 
observed in vivo. Furthermore, this model system permitted investigation of chemokine secretion as 
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part of the Senescence Associated Secretory Phenotype (SASP) (15). The chemotactic effect may 
lead to the recruitment of further immune cells and therefore progression of disease by increased 
necroinflammation. This represents a shift in thinking from the epithelium as a passive recipient of 
injury to a potential effecter in immunologically mediated disease. 
While these data are interesting, it remains unclear whether such bile duct responses occur only in 
the setting of persistent chronic inflammatory disease or whether they are also seen early in 
response to BEC injury, as implied by Nakanuma’s group(16). While the ability of senescent BEC to 
induce chemotaxis of immune cells and stellate cells has been assessed, there has been no 
conclusive proof of a direct mechanism by which senescence of these cells may lead from acute to 
chronic disease or an assessment of the fibrogenic potential of senescent cells. 
This study was designed to evaluate the presence of senescent BEC in acute cellular rejection by 
evaluating the association between senescent biliary cells and the grade of acute cellular rejection in 
transplant biopsies.  To investigate the possible underlying mechanism linking acute injury to disease 
severity and possible progression, the potential of senescent biliary epithelium to secrete pro-
apoptotic, pro-fibrogenic and immunomodulatory factors in the SASP was then explored using a 
model system in vitro.  
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Materials and methods 
Ethics 
Approval was obtained from a local regional ethics committee for the use of anonymised patient 
samples (approval reference: REC 06/Q0905/150). All patients were treated on a standard algorithm 
receiving prednisolone, Tacrolimus and Azathioprine. All biopsies were taken before escalation of 
therapy  
Immunohistochemical (IHC) triple staining of human liver biopsies  
Paraffin embedded tissue sections were de-waxed and rehydrated. Antigen retrieval was followed 
by blocking and peroxide incubation to quench endogenous peroxidase activity. Primary antibody 
was then added (anti-p21
WAF1/Cip1 
(Santa Cruz) 1:50 or anti-CD3 (DAKO) 1:100) or Ki67 (Immunotech) 
followed by biotinylated goat anti-mouse IgG (Vector, 1:200) and developed with Nickel 3,3’ 
diaminobenzidine tetrahydochloride  (NiDAB). A serial incubation with anti-Cytokeratin 19 (DAKO; 
1:1000) and anti S100A4 (BD, 1:200) followed with subsequent addition of peroxidase conjugated 
horse anti-mouse IgG (Vector; 1:100; developed with 3, 3’ diaminobenzidine tetrahydochloride 
(DAB)) and biotinylated goat anti-rabbit IgG (Vector; 1:200; developed with the Vector ABC-AP kit). 
Sections were countestained, dehydrated and mounted with DPX. Dual and single stains were 
performed in a similar manner, with inclusion of the γH2AX antibody (Cell Signal). 
Analysis 
The cases represented 9 ‘time zero’ biopsies (tissue taken at the point of intraoperative reperfusion 
of a transplanted liver) as control tissue and 25 biopsies of transplanted liver with varying grades of 
acute rejection (mild, moderate and severe, with all biopsies taken before augmentation of 
immunosuppression). The sections were scanned using an Aperio slide scanner at x20 and remotely 
accessed files were analyzed. Each biopsy was assessed by two observers (JGB and HR) and scored 
for number of portal tracts, number of bile duct radicles, maximum number of bile ducts per portal 
tract, number of p21
WAF1/Cip1
 positive BEC, number of S100A4 BEC, number of dual stained BEC 
(S100A4 and p21
WAF1/Cip1
) and number of p21
WAF1/Cip1
 and S100A4 BEC adjacent to one another. There 
was good agreement between the observers, any discrepancies were noted and a consensus opinion 
reached. As a number of immune cells stain positive for S100A4, there was a chance that infiltrating 
macrophages or T cells could be mistaken for BEC. This was usually straightforward to assess 
morphologically. For control experiments 14 separate cases (5 time zero and 9 acute cellular 
rejection) were stained with Ki67/S100A4/CK19 to act as a proliferation marker control group. A 
further 8 cases of post transplant biliary anastomotic injury/stricture were stained with 
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p21
WAF1/Cip1
/S100A4/CK19 as positive control tissue. To further support the presence of senescent 
cells 15 cases (10 ACR and 5 time 0) were labelled with antibodies specific for Ki67 and gH2AX. 
Cell culture 
The immortalized H69 cell line was created by, and obtained from, Grubman (17) from human 
intrahepatic BEC. These cells exhibit characteristics of normal human biliary epithelium, with 
expression of CK7 and 19. The H69 cells were cultured as described (17)  
Primary biliary epithelial cells were isolated from human explanted livers and cultured on 
plasticware coated with rat tail collagen as described (18).  
Immunofluorescence and densitometry 
For immunofluorescence experiments, immortalised BEC were seeded onto glass 8-chamber slides 
(Becton Dickinson, UK) at 50,000 cells per chamber with 250µl of culture medium. Cells were 
cultured for 24-48h until a confluent monolayer was formed. Following optimisation, cells were 
subjected to oxidative stress by the addition 200µM H2O2 (final concentration) for 2 hours followed 
by washing with PBS and addition of fresh culture medium. After 24, 48, 72, 96 or 120 hours the cells 
were fixed with 4% phosphate-buffered paraformaldehyde and permeabilised with 0.1% Triton X-
100. The cells were then blocked with 5% BSA. 
Primary antibodies specific for S100A4 (DAKO, 1:100), αSMA (Sigma, Poole, UK, 1:100), E-cadherin 
(BD Biosciences, Oxford, UK 1:50), ZO-1 (Invitrogen, NY, USA, 1:100), p21
WAF1/Cip1
 (Santa Cruz, Santa 
Cruz, USA,  1:100), fibronectin (Sigma, Poole, UK, 1:100) or vimentin (DAKO, Cambridge, UK, 1:100) 
were added in 5% BSA. For each time point and antigen a no-primary antibody treated preparation 
and a non-specific isotype/species specific primary antibody preparation were used as negative 
controls. The cells were then washed with 0.1% Tween-20 in PBS prior to addition of FITC-
conjugated anti-mouse or anti-rabbit (DAKO, Cambridge, UK, 1:100) secondary antibody in 5% BSA. 
Following washing slides were stained with DAPI (at a concentration of 1µg/ml). Slides were then 
washed in PBS and mounted in fluorescence mounting medium (DAKO, Cambridge, UK). Storage was 
at 4ºC.   
Visualisation was by immunofluorescence using a Leica TCS SP2 UV laser-scanning confocal 
microscope (LSCM) to detect FITC (excitation 488nm, emission 510-535nm) and DAPI (excitation 
peak 360nm, emission 450-550nm). Emission levels were set against a control section. 
Representative z-series were taken of each section/specimen and used for densitometric and 
morphological analysis. Densitometry analysis was by ImageJ software. All experiments were 
conducted in triplicate.  
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Western blotting 
 
Immortalised BEC growing in 75cm
2 
flasks were washed and 100µl of lysis buffer (Phosphosafe™ 
Merck KGaA, Darmstadt, Germany) added. Total protein concentration was estimated by BCA 
protein assay kit (Pierce, USA). This allowed production of a standard curve for absorbance at 
562nm. Extracts were stored at -20ºC. For SDS-PAGE, samples were supplemented with 10% β-
mercaptoethanol and 4x NuPAGE sample buffer (Invitrogen, NY, USA), before boiling, cooling and 
addition to SDS-PAGE gels.    
  
20µg of total protein lysate per well was separated by 4-12% gradient Sodium-dodecyl sulphate 
Polyacrylamide gel electrophoresis (SDS-PAGE). Separation was carried out using stable voltage, 
(20V per gel). Separated proteins were transferred from the gel to Hybond-P nitrocellulose 
membrane (Amersham Pharmacia Biotech, UK) overnight at 50mA. Non-specific antibody binding 
sites on the membrane were blocked with 5% skimmed milk in TBS. Primary antibodies were diluted 
in 5% milk/TBS to optimal concentrations. Membranes were incubated with primary antibodies 
overnight before washing in TBS supplemented with 0.1% Tween-20.  Membranes were then 
incubated with secondary antibodies conjugated with HRP (Horse Radish Peroxidase). After washing, 
the membrane was developed using Pierce Pico Chemiluminescence kit (Pierce, UK). Visualisation 
was by use of G-Box CCD camera (Syngene, Cambridge, UK).  
Following development, membranes were stripped of antibodies with stripping buffer (62.5M Tris, 
2% SDS, 100mM β-mercaptoethanol, pH 6.8). Membranes remained in the cooling buffer with 
agitation for a further 30 minutes. Membranes were washed in TTBS, re-blocked in 5% skimmed milk 
and incubated overnight with anti-β-tubulin antibody (Sigma, Poole, UK 1:5000) in 5% skimmed milk 
and TBS. Secondary antibody was anti-rabbit HRP conjugated antibodies (Sigma, Poole, UK 1:5000) 
with development as for primary antibodies. The intensity of β-tubulin was used to validate equal 
loading.   
ELISA 
ELISA kits specific for the TGF-β1 and TGF-β2 isoforms were purchased from R&D Systems (UK). Cell 
culture medium from two separate time courses was retained for analysis. This was treated with 
acid (50µl 6M HCl per ml medium for 10 minutes followed by neutralisation with 50µl per ml of 6M 
NaOH) in order to assess total rather than the active amount of TGF-β. The kits were used in 
accordance with the manufacturer’s instructions.   
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Real-time Quantitative Polymerase Chain Reaction (qPCR)  
RNA isolation was performed according to the method developed by Chomczynski and Sacchi(19). 
TRIzol reagent (Sigma) was used according to the manufacturer’s instructions. RNA was quantified 
and quality assessed using a nanodrop spectrophotometer (NanoDrop ND-1000, Thermo Scientific, 
Wilmington USA.). Isolated RNA was reverse transcribed to cDNA using the AffinityScript Multi 
Temperate cDNA synthesis kit (Agilent technologies) according to the manufacturer’s instructions.   
The qPCR experiments in this project utilised TaqMan (Applied Biosystems) chemistry and were 
performed in a MicroAmp Optical 96 well plate (Applied Biosystems) on a StepOnePlus real-time PCR 
machine (Applied Biosystems) with each well containing 1ul TaqMan primer-probe (all primers were 
exon-spanning), 1ul cDNA, 10ul Mastermix and 8ul RNase free water.. Triplicate technical replicates 
were performed for each experiment with GAPDH serving as the housekeeping control.   
Statistical analysis 
 Statistical analysis was performed using Prism software version 5.0 (Graph Pad Software, San Diego, 
USA). Parametric data was assessed by Student’s t-test or one way ANOVA. Statistical significance 
was defined as a p-value of 0.05 or less. All error bars represent the standard error of the mean 
(SEM). Non-parametric data was analysed by the Kruskall-Wallis test. 
 
Results 
Senescence and plasticity markers in human liver transplant biopsies 
Triple colour immunohistochemistry of transplant biopsies and time zero controls were scored and 
are shown in Figure 1, panels A-E. S100A4 cells (red) are clearly delineated, as is the strong nuclear 
positivity of p21WAF1/Cip (black), allowing co-localisation with the BEC specific CK19 (brown). 
p21
WAF1/Cip
 positive cells indicated senescence and those positive for S100A4 indicated de-
differentiation/presence of cellular plasticity. During assessment, dual positive S100A4 and 
p21
WAF1/Cip1
 positive biliary epithelial cells were not seen. Also, there were few examples of adjacent 
p21
WAF1/Cip1 
and S100A4 positive BEC. Blue arrows indicate infiltrating S100A4 positive cells, black 
arrows show BEC stained with either S100A4 or p21.  
Analysis showed significant increase of p21
WAF1/Cip1
 (p=0.034) and S100A4 (p=0.0068) positivity per 
bile duct with increasing grades of acute cellular rejection (Figure 1, panels F, G). Using the 
Spearman correlation test it was demonstrated that there was a statistically significant correlation 
(p=0.0013) between the expression of S100A4 and p21
WAF1/Cip1
 (Figure 1, panel H). 
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As previously described(20)  p21
WAF1/Cip1
 alone is not a specific marker for senescence, though it is 
much more specific when described in Ki67 negative cells. In line with the published literature(20, 
21) the presence of Ki67 negative/γH2AX positive cells is regarded as the gold standard for 
senescence detection. To define whether there was further evidence of senescence in ACR; biopsies 
were also stained for Ki67 and γH2AX. γH2AX positivity was defined by the presence of more than 5 
positive foci per nucleus. Cells positive for γH2AX (and negative for Ki67) were seen with increasing 
frequency (Figure 2 panels I-K) in cases with increasing ACR grade. For completeness dual staining of 
Ki67 and p21
WAF1/Cip1
 was performed (Figure 2 panels L-N). This showed that Ki67 negative 
p21
WAF1/Cip1
 positive cells were present. Enhanced production of reactive oxygen species is another 
component of the senescent phenotype, leading to accumulation of autofluorescent, lipofuscin-like 
material (Passos et al. 2010). BEC in ACR show greatly enhanced autofluorescence (supplementary 
Fig S3). 
Proliferation and plasticity markers in human liver transplant biopsies 
Triple colour immunohistochemistry was performed for the markers Ki67 (black), S100A4 (red) and 
CK19 (brown) (Figure 2 panels A-C). As previously reported in the literature there was an increase in 
the Ki67 positive cells with increasing grade of rejection. 80-85% of the Ki67 positive cells in 
moderate or severe rejection were also co-stained with S100A4; those that were not co-stained 
were adjacent to S100A4 positive BEC. The majority of S100A4 positive BEC were not dual stained 
for Ki67 as shown in panel C. Figure 2 Panels D-H show images of biopsies from transplant recipients 
with biliary anastomotic stenosis or obstruction. Stains are p21
WAF1/Cip 
(black), S100A4 (red) and CK19 
(brown). 
Oxidative stress-induced senescence in BEC cultures 
Following treatment by H2O2 immortalised BEC were assessed for senescence by detection of 
nuclear p21
WAF1/Cip1
 expression as this is related to cell cycle arrest and senescence(22). The numbers 
of positive nuclei per high power field (x20 lens; LSCM) were counted, with one field from each of 
the triplicate of experiments included in the analysis. Treatment with H2O2 at 200µM for 2 hours 
produced significant nuclear expression of p21
WAF1/Cip1
 after 48 or 72 hours, consistent with the 
literature.  
Peak p21
WAF1/Cip1
 expression was after 48 hours, with a rapid decline after this time (Figure 3 panels 
A-E). This was assessed by one way ANOVA  p<0.0001. Post hoc t-tests showed that control versus 
48 and 72 hours were significant at p<0.001. The rise in expression between 24, 48 and 72 hours 
were all significant at p<0.001. Comparable findings were demonstrated using primary BEC, where 
untreated cells showed no expression of p21
WAF1/Cip1
, 200µM hydrogen peroxide gave a rapid up 
Page 12 of 64
ScholarOne support: (434) 964 4100
American Journal of Transplantation
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
IN SUBMISSION
11 
 
regulation in nuclear p21
WAF1/Cip1
 at 48 hours with down regulation after 72 hours (inset images 
Figure 3 panels A and C).  
Oxidative stress- induced epithelial de-differentiation in BEC cultures 
Immortalised BEC showed a morphological change 72 h after exposure to H2O2 from typical 
cobblestone to spindle cell morphology with increased expression of S100A4, a marker of de-
differentiation (Figure 4 panels A-E).  This morphology was consistent with the de-differentiation 
seen when immortalised BEC cells are exposed to TGF-β1 (23). Triplicate cultures of immortalised 
BEC were exposed to 200µΜ H2O2 for two hours followed by incubation for 24, 48, 72, 96 or 120 
hours. To control for potential tissue culture induced changes, triplicate cultures were plated and 
incubated for the same length of time as the treated cultures, with no change in morphology of 
expression. At all time-points, cultures were stained for αSMA (Figure 4 panels K-O), S100A4 (Figure 
4 panels A-E), fibronectin, Vimentin and ZO-1 (Figure 4 panels F-J). In all cases, the secondary 
antibody was FITC-conjugated (green fluorescence, Figure 4). Densitometric analysis was performed 
to quantify changes in antigen expression. This involved assessment of a defined area of each Z 
series obtained, one field from each of the three cultures. These data are presented in Figure 4 
panels P-R. For each antigen a one-way ANOVA was performed, showing statistical difference in the 
expression of S100A4 (p=0.0096), αSMA (p=0.0348) and ZO-1 (p=0.0018). Post-hoc t tests 
demonstrated that αSMA expression was significantly increased at 48 hours compared to control 
and also increased between 24 and 48 hours. ZO-1 expression was significantly decreased at 24, 48 
and 120 hours versus control. 
Further data from the time points of maximum expression of αSMA and S100A4 (48 and 72 hours) 
showed an increase in expression of ECM components fibronectin (p=0.0176) and Vimentin 
(p<0.0001) (Figure 5 panels A-F, H and I). In order to provide further support for this change in 
antigen expression, cell lysates were separated by SDS-PAGE and the membranes probed using the 
same antibodies. These showed expression of fibronectin (at correct molecular weight, Figure 5 
panel G) that increased from baseline, peaking at 48-72 hours. Following all other experiments the 
cells that had been passaged were stained for the epithelial markers in order to verify that the 
immortalised BEC cell lines had retained their epithelial characteristics. These cells exhibited strong 
baseline staining for CK19 and E-cadherin (supplementary data Figure 1).    
Oxidative stress-induced de-differentiation of cultured BEC is TGF-β dependent 
To determine whether the observed de-differentiation in immortalised BEC was due TGF-β 
signalling, cell culture medium from peroxide treated immortalised BEC was retained to perform 
TGF-β ELISA. Following acid treatment to permit total TGF-β to be detected, these media were 
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assayed in triplicate against controls. These data demonstrated TGF-β1 levels to be not significantly 
raised; whereas TGF-β2 levels were raised significantly over time (p = 0.006, Figure 6).   
In order to demonstrate causality in this in vitro system, a triplicate culture of immortalised BEC was 
incubated with a TGF-β type 1 receptor serine/threonine kinase (ALK5) inhibitor (SB-505124) at an 
optimal concentration of 1µΜ (data not shown), for one hour before exposure to 200µΜ H2O2 for 
two hours followed by incubation for a further 72 hours before staining for the antigens S100A4, ZO-
1, p21 and αSMA (Figure 7 Panels A-F). Densitometric analysis was performed as above (Figure 7 
panels G and H). The increased expression of S100A4 and αSMA and the decrease in ZO-1 normally 
produced by H2O2 exposure were almost completely abrogated by inhibition of TGF-β signalling. 
Statistical analysis between the SB-505124 treated and untreated, H2O2 exposed groups at 72 hours, 
by two-way ANOVA was positive at p < 0.0001.     
TGF-β and p21WAF1/Cip1 RNA Expression in BEC cultures 
Both immortalised and primary BEC were assessed for the expression of mRNA encoding p21
WAF1/Cip1
, 
TGF-β1 and TGF-β2. Figure 8 demonstrates a clear increase in p21
WAF1/Cip1
 expression (panel A) 
peaking at 12 hours after treatment with H2O2 before falling back to baseline by 24 hours. TGF-β1 
showed a slight increase at 12 hours whereas TGF-β 2 showed a significant 6 fold increase (Figure 8 
panel C) at 4 hours which was sustained, falling back to near baseline by 24 hours. To determine if 
the observed expression of p21
WAF1/Cip1 
in primary BEC was also associated with TGF-β expression, 
primary BEC were either untreated or treated with 200µM hydrogen peroxide and incubated for 6 or 
12 hours from initial exposure and treated as the immortalised BEC. The primary cells also showed 
an increase in p21
WAF1/Cip1
 (Figure 8 panel D) and TGF-β2 expression (Figure 8 panel F) at 6 hours 
followed by a fall back to baseline by 12 hours. There was only a decrease in TGF-β1 expression 
(Figure 8 panel E). 
 
 
Activation of TGF-β by BEC 
In order to assess the potential of BEC to activate latent TGF-β, immortalised BEC cultures were 
assessed for their ability to up regulate β6 integrin. Immortalised BEC were either used without 
treatment or following 200µM H2O2 for 2 hours and incubation for 24 or 48 hours. At baseline 
expression of β6 integrin was not present; there was a significant up regulation in response to 
oxidative stress (P<0.001; supplementary figure 2). 
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Discussion 
This study suggests that cellular senescence plays a key role in acute cellular rejection of liver 
allografts. A clear positive correlation was demonstrated between the number of p21
WAF1/Cip1
 positive 
biliary epithelial cells and increasing grade of acute rejection.  This is consistent with data from other 
groups detailing severity in chronic cholestatic liver diseases (10, 13, 16). In addition to its role as a 
marker of senescence, p21
WAF1/Cip1
 can also be upregulated during the G1 phase of the cell cycle(24).  
Ki67 is a marker of proliferation present throughout all active phases of the cell cycle (25). In order 
to differentiate senescent and proliferating cells, Ki67 was used in a triple label in place of 
p21
WAF1/Cip1
. This demonstrated that Ki67 and p21
WAF1/Cip1
 positive BEC occupy different cellular 
niches. Whereas p21
WAF1/Cip1
 positive cells never co-stained for S100A4 and were never seen adjacent 
to S100A4 stained BEC, Ki67 stained cells were always either co-stained for S100A4 or adjacent to 
S100A4 positive BEC in moderate to severe rejection (though in mild rejection Ki67 positive cells 
were seen in the absence of S100A4). These results are compatible with a model in which the BEC 
that express p21
WAF1/Cip1
 are non-proliferating, senescent cells whilst other BEC, which may also 
express S100A4, are actively proliferating. The presence of the senescence marker γH2AX was also 
assessed, this being regarded as a gold standard for the assessment of senescence(20). In sections of 
ACR; Ki67 negative, γH2AX positive cells were identified with increasing frequency in line with 
increasing Banff grade. This would strongly suggest that senescent cells are indeed present in 
increasing number with increased Banff grade, in line with our observations of p21
WAF1/Cip1
. The dual 
staining of p21
WAF1/Cip1 
and Ki67 was also performed, showing the presence of Ki67 negative 
p21
WAF1/Cip1
 positive cells in ACR. 
An in vitro model was established to investigate the possible link between senescence and epithelial 
de-differentiation. This initially aimed to replicate the findings of Nakanuma et al (8, 14), before 
evaluating the SASP in relation to epithelial plasticity. Transient increases in p21
WAF1/Cip1
 expression 
by both immortalised and primary BEC were observed after oxidative stress. Staining for further 
antigens also revealed that immortalised BEC spontaneously underwent de-differentiation following 
peroxide exposure. This is consistent with observations reported previously for respiratory 
epithelium (26, 27). The phenotype of the primary and immortalized BEC differed in that primary 
BEC retained their CK19 expression more than immortalised BEC and also retained a more epithelial 
morphology at respective time points. This may be due to the immortalisation process or the 
presence of a collagen rich scaffold(28), therefore caution must be taken in extrapolating the 
proteomic results from the in vitro to in vivo environments. 
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Several groups have studied factors that may drive epithelial de-differentiation downstream of TGF-
β, including Sonic Hedgehog(29-31) and Jagged/Notch(32) (e.g.). However, the factor or factors 
driving oxidative stress-induced epithelial de-differentiation have not been defined. While the 
expression of chemokines and interleukins has been studied in relation to the SASP in BEC, the 
expression of TGF-β has not (8, 33). Passos (34) described a putative pathway in fibroblasts 
undergoing replicative senescence and expressing p21
WAF1/Cip1
 that would increase the expression of 
TGF-β receptors and the TGF-β2 isoform. To evaluate this, total TGF-β was quantified from the cell 
culture medium of two time-course experiments using ELISAs specific for TGF-β1 and TGF-β2. These 
assays showed a slight decrease in total TGF-β1 expression but a four-fold increase in total TGF-β2. 
To support that this was indeed the mechanism producing the observed de-differentiation, the ALK-
5 (TGF-β type I) receptor was blocked using a specific and non-toxic pharmacological inhibitor SB 
505124(35). This inhibitor prevented the observed de-differentiation changes normally produced in 
response to peroxide. This is consistent with the described differential expression of TGF-β1 and β2 
transcripts in rodent and human liver fibrosis (36) with a restriction of TGF-β2 transcripts to the 
biliary epithelium.  
To demonstrate that the expression of p21
WAF1/Cip1 
and TGF-β was due to increased transcription, 
qPCR of isolates from both immortalised and primary BEC were performed. This showed that there 
was indeed a transient increase in transcripts for p21
WAF1/Cip1
 and TGF-β2 in both cell types. One of 
the potential confounding factors of using the immortalised BEC is interruption of the p53 signaling 
pathway by the SV40 large T antigen, the agent used in immortalising these cells(37). However, it 
was shown that up regulation of both p21
WAF1/Cip1
 and TGF-β2 is independent of any action of SV40 
as similar expression profiles were produced by the same stimulus in both immortalised and primary 
BEC. However, a difference in the kinetics of this up-regulation was observed, with primary BEC 
showing increases at earlier time points than immortalised BEC. This is likely due to the stabilizing 
effects of SV40 on p21
WAF1/Cip1
 expression, as this is a downstream effecter of p53(38). Ultimately the 
profiles of gene expression in these cells are comparable within this system and serve to support the 
use of immortalised BEC as an appropriate model.  
TGF-β is produced initially as a pro-protein which is cleaved by furin-like proteases to yield a small 
latent complex consisting of dimeric TGF-β which is concealed by two Latency Associated Peptides 
(LAP), This inactive complex can be activated by interaction with the αvβ6 integrin(39-41) which can 
bind an RGD motif on the LAP leading to a conformational change. The current study showed that 
resting BEC did not express the β6 integrin, but this was induced following exposure to oxidative 
stress potentially allowing these cells to activate latent TGF-β.   
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It has already been shown that expression of markers of proliferation in BEC correlates with Banff 
grade(25, 42). p21
WAF1/Cip1
 can be up regulated as a consequence of cell cycle regulation, replicative 
senescence (associated with telomere shortening) or as a result of oxidative stress and other cell 
damage (e.g. p53 mediated) pathways(22). Acute injurious stimuli can, therefore, lead to senescence 
in the biliary epithelium, which causes an up-regulation in p21
WAF1/Cip1
. This triggers chemokine and 
TGF-β2 production, which may drive disease progression. In vitro this is observed as de-
differentiation in response to TGF-β2. This response is also seen in primary BEC indicating that this is 
highly likely to model the in vivo response of the biliary epithelial compartment to injury. The 
presence of senescent BEC in ACR may suggest a link between acute and chronic rejection. 
Senescent BEC are a well described feature of chronic ductopaenic rejection(43) and as the number 
of senescent cells correlates with Banff grade(44), so does the probability of future chronic rejection. 
Chronic rejection has changed, most likely modified by newer anti-rejection agents, the underlying 
biology of which is not currently understood. Expression of TGF-β subtypes by the biliary epithelium 
also has the potential to modify the immune system, with a likely increase in regulatory T cells as 
well as a promotion of wound healing/fibrosis  
We have provided observational evidence of intermediate “plastic” cell types in the bile ducts of 
human liver biopsies undergoing acute rejection. As a marker of plasticity, it must be remembered 
that S100A4 is also present in certain normal cell types including macrophages(45) and in the cells of 
the peribiliary glands(46). Expression of S100A4 has been clearly shown in BEC in the finer branches 
of the biliary tree and anatomically distinct from the peribiliary glands which are preferentially 
associated with the intrahepatic large bile ducts. In replicating these findings in vitro, we have 
observed de-differentiation, driven by TGF-β2. Interestingly the response of the immortalised BEC to 
oxidative stress was to adopt a CK19-, ZO-1-, S100A4+, αSMA+ phenotype and an irregular, stellate 
morphology. These cells therefore exhibited some characteristics of myofibroblasts and activated 
Hepatic Stellate Cells (HSC) (15).  Any potential role for these stellate-like biliary epithelial cells in 
vivo is however uncertain.  
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Figure legends: 
Figure 1: Triple colour immunohistochemistry of senescence and plasticity 
markers in human liver transplant biopsies. Panels A-E represent photomicrographs 
depicting the relative staining attained using the three colour technique. Brown staining reflects 
CK19 expression, Black p21
WAF1/Cip 
and red S100A4. Cells staining dual positive for S100A4 and CK19 
are shown with black arrows. Infiltrating cells (blue arrow) were excluded morphologically or with 
reference to further immunohistochemistry. Panel A represents a time zero biopsy, used as control.  
Panel B and C mild acute cellular rejection and panels D and E moderate and severe ACR 
respectively. Inset image shows section stained with no primary antibody. Panels F-H show graphs 
attained by scoring the biopsies. Panel F indicates the number of S100A4 positive biliary epithelial 
cells per bile duct, with a clear increase with increasing grade of acute cellular rejection. Panel G 
indicates the same association with S100A4 p21
WAF1/Cip
 expression and Panel H Shows the correlation 
between S100A4 and p21 expression. 
Figure 2: Triple colour immunohistochemistry of proliferation markers 
and control human transplant biopsies. Panels A-C represent Transplant biopsies 
stained for Ki67 (black), S100A4 (red) and CK19 (brown). Panels A demonstrates mild rejection and 
Ki67 positive BEC are clearly seen in the absence of S100A4. Panel B shows Ki67 and S100A4 dual 
positive BEC in moderate rejection, with the spatial relationship between single positive S100A4 or 
Ki67 positive BEC apparent. Panel C Shows a field from a severe rejection biopsy, indicating the 
number of S100A4 positive BEC relative to Ki67 positive BEC. Panels D-H Represent fields from 
human liver transplant recipients with biliary anastomosis obstruction or stricturing. These are 
stained with p21
WAF1/Cip 
(black), S100A4 (red) and Ck19 (brown) as control material. The abundance 
of staining for all antigens is apparent. Panels I – K show dual staining for Ki67 (brown) and γH2AX 
(black) Panel I shows ACR biopsy material, the main image is a negative control, the inset image is a 
single stained γH2AX, showing the characteristic punctate nuclear staining pattern. Panel J is from a 
moderate ACR biopsy, clear Ki67 negative and γH2AX positive cells are seen. Panel K shows a severe 
ACR biopsy with a clear increase in the numbers of Ki67 negative and γH2AX positive cells. Panels L-N 
show dual stained Ki67 (brown, brown arrows) and p21
WAF1/Cip1 
(black, black arrows). Panel L is from 
a mild ACR showing only Ki67 positivity, Panel M is moderate and panel N severe ACR. 
Figure 3: Photomicrographs demonstrating p21WAF1/Cip expression. The nuclei 
of the Immortalised BEC are visualised with DAPI and are blue.  p21
WAF1/Cip 
is stained with FITC and is 
green. Panels A, B, C, D and E show results observed at time 0, 24, 48, 72 and 120 hours respectively. 
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The increase in nuclear p21
WAF1/Cip
 staining is seen with a peak at 48 hours. Staining seen at 72 hours 
is largely cytoplasmic, indicating phosphorylated and therefore inactive p21
WAF1/Cip
. The nuclear 
staining is shown graphically in panel F, 3 representative fields from 3 separate experiments at each 
time point. Primary BEC were also stained, images are shown inset for control (inset A) and at 48 
hours (inset C).   
Figure 4: Photomicrographs depicting change in antigen expression over 
time. Each photomicrograph is a representative sample from triplicate experiments. The incubation 
period post peroxide exposure is noted along the top. Panels A-E show the change in S100A4 
expression, F-J the change in ZO-1 expression and K-O the change in α-SMA expression. Significant 
changes in morphology can be seen, with spindle cell morphology apparent  after 48 hours. For each 
of the antigens ZO-1, α-SMA and S100A4, densitometric analysis was performed as described in 
methods. The results are tabulated in panels P-R, based on triplicate readings with the mean and 
standard error shown. Clear changes in expression of the antigens are seen, with increasing S100A4 
and α-SMA and decreasing ZO-1 expression statistically significant (one way ANOVA) at p = 0.0096 
(S100A4), aSMA at p = 0.0068 and ZO-1 at 0.0087.  
 
Figure 5: Extracellular matrix expression. The expression of extracellular matrix 
components was assessed by fluorescence microscopy and confirmed by western blot. The 
expression of Vimentin (panels A-C) and Fibronectin (panels D-F) is clearly absent at baseline but is 
apparent at 48 and 72 hours post peroxide exposure. The fluorescence was quantified by 
densitometry and data shown in panels H and I (significant after 72 hours at p = 0.0273 and p = 
0.0241 respectively). Cell lysates from all time points are shown, following separation by SDS-PAGE 
(Panel G), and also show a significant increase in fibronectin expression. 
Figure 6: TGF-β ELISA. Two ELISAs were performed to assess total TGF-β expression. The level 
of TGF-β1 (panel A) appears largely constant but the expression of TGF-β2 (panel B) shows almost a 
four-fold increase between time 0 and 72 hours (P = 0.0058), where it appears to plateau before 
falling sharply.   
Figure 7: TGF-β receptor blockade. Panels A-C show antigen expression at 72 hours post 
H2O2 exposure as seen in Figure 3. Panels D-F show antigen expression of immortalised BEC cells 
that were treated with the ALK-5 inhibitor SB-505124 at 1µM for 1 hour before H2O2 exposure and 
incubation for 72 hours; no induction of αSMA or S100A4 was observed whilst ZO-1 expression was 
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retained. Densitometric analysis is presented in panels G and H; two way ANOVA shows statistical 
significance at p<0.0001. 
Figure 8: qPCR of immortalised and primary BEC. Graphs shown represent triplicate 
replicates of representative qPCR experiments. Panels A-C show expression of mRNA in 
immortalised BEC cells at time points after exposure to 200µM H2O2. Panels D-F show expression of 
mRNA in primary BEC at time points after 200µM H2O2 exposure. One way ANOVA showed 
p21
WAF1/Cip 
expression to be significant at p < 0.001 (immortalised BEC) and p = 0.0285 (primary BEC) 
and TGF-β2 expression to be significant at p < 0.001 (immortalised BEC) and p = 0.042 (primary BEC) 
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List of abbreviations: 
ACR  Acute Cellular Rejection 
aSMA  alpha Smooth Muscle Actin 
BEC  Biliary epithelial cells 
DAPI   4′,6-diamidino-2-phenylindole 
cDNA  complementary DNA 
DMEM   Dulbecco modified Eagle medium 
ECM  extracellular matrix 
ECL  enhanced Chemiluminescence 
H2O2  Hydrogen peroxide 
HRP  horseradish peroxidase 
HSC  Hepatic stellate cells 
HSA  human serum albumin 
FITC  fluorescein isothiocyanate 
GAPDH  glyceraldehyde-3-phosphate 
LAP  Latency Associated Peptides  
LSCM  laser-scanning confocal microscope  
PAGE  polyacrylamide gel electrophoresis 
PCR  polymerase chain reaction 
PVDF  polyvinylidene diflouride 
R  correlation coefficient 
ROS  reactive oxygen species 
SASP  Senescence associated secretory phenotype 
SDS  Sodium-dodecyl sulphate 
TBS  triethanolamine-buffered saline 
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Abstract 
Biliary epithelial cells (BEC) are important targets in some liver diseases, including acute allograft 
rejection. Although some injured BEC die, many can survive in function compromised states of 
senescence or phenotypic de-differentiation. This study was performed to examine changes in the 
phenotype of BEC during acute liver allograft rejection and the mechanism driving these changes. 
Liver allograft sections showed a positive correlation (p<0.0013) between increasing T-Cell mediated 
acute rejection and the number of BEC expressing the senescence marker p21
WAF1/Cip
 or the 
mesenchymal marker S100A4.  This was modelled in vitro by examination of primary or immortalised 
BEC after acute oxidative stress. During the first 48 hours, the expression of p21
WAF1/Cip
 was increased 
transiently before returning to baseline. After this time BEC showed increased expression of 
mesenchymal proteins with a decrease in epithelial markers. Analysis of TGF-β expression at mRNA 
and protein levels also showed a rapid increase in TGF-β2 (p<0.006) following oxidative stress. The 
epithelial de-differentiation observed in vitro was abrogated by pharmacological blockade of the 
ALK-5 component of the TGF-β receptor. These data suggest that stress induced production of TGF-
β2 by BEC can modify liver allograft function by enhancing the de-differentiation of local epithelial 
cells.   
 
Key words: Liver, Epithelial de-differentiation, Biliary disease, Allograft rejection 
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Introduction 
The rate of acute cellular rejection in liver allografts has fallen from 60-70% to 10-20% of graft 
recipients and classical ductopaenic rejection has all but disappeared from clinical practice(1). 
However, this reduction has been accompanied by an increase in factors limiting the quality and 
length of life of liver transplant recipients (1-3). There are significant sequelae associated with the 
administration of immunosuppressive agents, stimulating interest in regimes designed to induce 
tolerance to liver grafts and the ability to maintain grafts with minimal or no immunosuppression(4). 
The limited evidence available also points to increased fibrosis in patients classed as tolerant, with 
no evidence of either acute or chronic rejection (4).  There is also interest in other phenomena 
associated with graft immune responses, such as non-classical antibody-mediated rejection and late 
acute cellular rejection(5, 6) 
While fibrosis is arguably a reversible endpoint, there has been little study of the factors determining 
transition from acute to chronic disease. Unlike other transplanted organs, there is evidence that 
patients suffering an episode of acute liver allograft rejection have a favourable outcome in terms of 
survival with a functioning graft(7), raising the possibility that acute rejection can have beneficial 
effects on the allograft immune infiltrate. Effects of biliary injury in this setting have not been 
studied; however, there has been recent interest in the response of the biliary epithelium during the 
development of ductopaenic liver disease, including chronic rejection(8-10). Lethally injured cells 
typically undergo either necrosis or apoptosis. However, sub-lethal injury can lead to a number of 
conserved processes including senescence(10) or autophagy(11). Cellular senescence is defined as 
loss of the ability to divide and can be induced by replication (exhaustive or replicative senescence) 
or toxic effects, for example from oncogenes or chemokines, and is well defined in chronic 
ductopaenic rejection(12). (12). In practical terms, defining senescence relies on the detection of 
phenotypic markers as it is not possible to follow the life cycle of cells in vivo. The functional 
definition of senescence could therefore be described as cells exhibiting markers, at the time of 
sampling, which indicate further division is unlikely.  There are no reports describing senescence in 
acute cellular rejection of liver allografts. 
Nakanuma et al(10, 13) have investigated the effect of senescence on biliary epithelial cells (BEC) in 
chronic biliary disease, demonstrating a correlation between number of senescent BEC and the 
progression of a number of diseases in human biopsies (8, 10, 13). In replicating the biopsy features 
in vitro, Sasaki et al. (14) used oxidative stress to induce murine biliary epithelial senescence.  
Exposure to hydrogen peroxide replicated the cell expression of the senescence marker p21
WAF1/Cip1 
observed in vivo. Furthermore, this model system permitted investigation of chemokine secretion as 
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part of the Senescence Associated Secretory Phenotype (SASP) (15). The chemotactic effect may 
lead to the recruitment of further immune cells and therefore progression of disease by increased 
necroinflammation. This represents a shift in thinking from the epithelium as a passive recipient of 
injury to a potential effecter in immunologically mediated disease. 
While these data are interesting, it remains unclear whether such bile duct responses occur only in 
the setting of persistent chronic inflammatory disease or whether they are also seen early in 
response to BEC injury, as implied by Nakanuma’s group(16). While the ability of senescent BEC to 
induce chemotaxis of immune cells and stellate cells has been assessed, there has been no 
conclusive proof of a direct mechanism by which senescence of these cells may lead from acute to 
chronic disease or an assessment of the fibrogenic potential of senescent cells. 
This study was designed to evaluate the presence of senescent BEC in acute cellular rejection by 
evaluating the association between senescent biliary cells and the grade of acute cellular rejection in 
transplant biopsies.  To investigate the possible underlying mechanism linking acute injury to disease 
severity and possible progression, the potential of senescent biliary epithelium to secrete pro-
apoptotic, pro-fibrogenic and immunomodulatory factors in the SASP was then explored using a 
model system in vitro.  
  
Page 29 of 64
ScholarOne support: (434) 964 4100
American Journal of Transplantation
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
IN SUBMISSION
6 
 
Materials and methods 
Ethics 
Approval was obtained from a local regional ethics committee for the use of anonymised patient 
samples (approval reference: REC 06/Q0905/150). All patients were treated on a standard algorithm 
receiving prednisolone, Tacrolimus and Azathioprine. All biopsies were taken before escalation of 
therapy  
Immunohistochemical (IHC) triple staining of human liver biopsies  
Paraffin embedded tissue sections were de-waxed and rehydrated. Antigen retrieval was followed 
by blocking and peroxide incubation to quench endogenous peroxidase activity. Primary antibody 
was then added (anti-p21
WAF1/Cip1 
(Santa Cruz) 1:50 or anti-CD3 (DAKO) 1:100) or Ki67 (Immunotech) 
followed by biotinylated goat anti-mouse IgG (Vector, 1:200) and developed with Nickel 3,3’ 
diaminobenzidine tetrahydochloride  (NiDAB). A serial incubation with anti-Cytokeratin 19 (DAKO; 
1:1000) and anti S100A4 (BD, 1:200) followed with subsequent addition of peroxidase conjugated 
horse anti-mouse IgG (Vector; 1:100; developed with 3, 3’ diaminobenzidine tetrahydochloride 
(DAB)) and biotinylated goat anti-rabbit IgG (Vector; 1:200; developed with the Vector ABC-AP kit). 
Sections were countestained, dehydrated and mounted with DPX. Dual and single stains were 
performed in a similar manner, with inclusion of the γH2AX antibody (Cell Signal). 
Analysis 
The cases represented 9 ‘time zero’ biopsies (tissue taken at the point of intraoperative reperfusion 
of a transplanted liver) as control tissue and 25 biopsies of transplanted liver with varying grades of 
acute rejection (mild, moderate and severe, with all biopsies taken before augmentation of 
immunosuppression). The sections were scanned using an Aperio slide scanner at x20 and remotely 
accessed files were analyzed. Each biopsy was assessed by two observers (JGB and HR) and scored 
for number of portal tracts, number of bile duct radicles, maximum number of bile ducts per portal 
tract, number of p21
WAF1/Cip1
 positive BEC, number of S100A4 BEC, number of dual stained BEC 
(S100A4 and p21
WAF1/Cip1
) and number of p21
WAF1/Cip1
 and S100A4 BEC adjacent to one another. There 
was good agreement between the observers, any discrepancies were noted and a consensus opinion 
reached. As a number of immune cells stain positive for S100A4, there was a chance that infiltrating 
macrophages or T cells could be mistaken for BEC. This was usually straightforward to assess 
morphologically. For control experiments 14 separate cases (5 time zero and 9 acute cellular 
rejection) were stained with Ki67/S100A4/CK19 to act as a proliferation marker control group. A 
further 8 cases of post transplant biliary anastomotic injury/stricture were stained with 
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p21
WAF1/Cip1
/S100A4/CK19 as positive control tissue. To further support the presence of senescent 
cells 15 cases (10 ACR and 5 time 0) were labelled with antibodies specific for Ki67 and gH2AX. 
Cell culture 
The immortalized H69 cell line was created by, and obtained from, Grubman (17) from human 
intrahepatic BEC. These cells exhibit characteristics of normal human biliary epithelium, with 
expression of CK7 and 19. The H69 cells were cultured as described (17)  
Primary biliary epithelial cells were isolated from human explanted livers and cultured on 
plasticware coated with rat tail collagen as described (18).  
Immunofluorescence and densitometry 
For immunofluorescence experiments, immortalised BEC were seeded onto glass 8-chamber slides 
(Becton Dickinson, UK) at 50,000 cells per chamber with 250µl of culture medium. Cells were 
cultured for 24-48h until a confluent monolayer was formed. Following optimisation, cells were 
subjected to oxidative stress by the addition 200µM H2O2 (final concentration) for 2 hours followed 
by washing with PBS and addition of fresh culture medium. After 24, 48, 72, 96 or 120 hours the cells 
were fixed with 4% phosphate-buffered paraformaldehyde and permeabilised with 0.1% Triton X-
100. The cells were then blocked with 5% BSA. 
Primary antibodies specific for S100A4 (DAKO, 1:100), αSMA (Sigma, Poole, UK, 1:100), E-cadherin 
(BD Biosciences, Oxford, UK 1:50), ZO-1 (Invitrogen, NY, USA, 1:100), p21
WAF1/Cip1
 (Santa Cruz, Santa 
Cruz, USA,  1:100), fibronectin (Sigma, Poole, UK, 1:100) or vimentin (DAKO, Cambridge, UK, 1:100) 
were added in 5% BSA. For each time point and antigen a no-primary antibody treated preparation 
and a non-specific isotype/species specific primary antibody preparation were used as negative 
controls. The cells were then washed with 0.1% Tween-20 in PBS prior to addition of FITC-
conjugated anti-mouse or anti-rabbit (DAKO, Cambridge, UK, 1:100) secondary antibody in 5% BSA. 
Following washing slides were stained with DAPI (at a concentration of 1µg/ml). Slides were then 
washed in PBS and mounted in fluorescence mounting medium (DAKO, Cambridge, UK). Storage was 
at 4ºC.   
Visualisation was by immunofluorescence using a Leica TCS SP2 UV laser-scanning confocal 
microscope (LSCM) to detect FITC (excitation 488nm, emission 510-535nm) and DAPI (excitation 
peak 360nm, emission 450-550nm). Emission levels were set against a control section. 
Representative z-series were taken of each section/specimen and used for densitometric and 
morphological analysis. Densitometry analysis was by ImageJ software. All experiments were 
conducted in triplicate.  
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Western blotting 
 
Immortalised BEC growing in 75cm
2 
flasks were washed and 100µl of lysis buffer (Phosphosafe™ 
Merck KGaA, Darmstadt, Germany) added. Total protein concentration was estimated by BCA 
protein assay kit (Pierce, USA). This allowed production of a standard curve for absorbance at 
562nm. Extracts were stored at -20ºC. For SDS-PAGE, samples were supplemented with 10% β-
mercaptoethanol and 4x NuPAGE sample buffer (Invitrogen, NY, USA), before boiling, cooling and 
addition to SDS-PAGE gels.    
  
20µg of total protein lysate per well was separated by 4-12% gradient Sodium-dodecyl sulphate 
Polyacrylamide gel electrophoresis (SDS-PAGE). Separation was carried out using stable voltage, 
(20V per gel). Separated proteins were transferred from the gel to Hybond-P nitrocellulose 
membrane (Amersham Pharmacia Biotech, UK) overnight at 50mA. Non-specific antibody binding 
sites on the membrane were blocked with 5% skimmed milk in TBS. Primary antibodies were diluted 
in 5% milk/TBS to optimal concentrations. Membranes were incubated with primary antibodies 
overnight before washing in TBS supplemented with 0.1% Tween-20.  Membranes were then 
incubated with secondary antibodies conjugated with HRP (Horse Radish Peroxidase). After washing, 
the membrane was developed using Pierce Pico Chemiluminescence kit (Pierce, UK). Visualisation 
was by use of G-Box CCD camera (Syngene, Cambridge, UK).  
Following development, membranes were stripped of antibodies with stripping buffer (62.5M Tris, 
2% SDS, 100mM β-mercaptoethanol, pH 6.8). Membranes remained in the cooling buffer with 
agitation for a further 30 minutes. Membranes were washed in TTBS, re-blocked in 5% skimmed milk 
and incubated overnight with anti-β-tubulin antibody (Sigma, Poole, UK 1:5000) in 5% skimmed milk 
and TBS. Secondary antibody was anti-rabbit HRP conjugated antibodies (Sigma, Poole, UK 1:5000) 
with development as for primary antibodies. The intensity of β-tubulin was used to validate equal 
loading.   
ELISA 
ELISA kits specific for the TGF-β1 and TGF-β2 isoforms were purchased from R&D Systems (UK). Cell 
culture medium from two separate time courses was retained for analysis. This was treated with 
acid (50µl 6M HCl per ml medium for 10 minutes followed by neutralisation with 50µl per ml of 6M 
NaOH) in order to assess total rather than the active amount of TGF-β. The kits were used in 
accordance with the manufacturer’s instructions.   
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Real-time Quantitative Polymerase Chain Reaction (qPCR)  
RNA isolation was performed according to the method developed by Chomczynski and Sacchi(19). 
TRIzol reagent (Sigma) was used according to the manufacturer’s instructions. RNA was quantified 
and quality assessed using a nanodrop spectrophotometer (NanoDrop ND-1000, Thermo Scientific, 
Wilmington USA.). Isolated RNA was reverse transcribed to cDNA using the AffinityScript Multi 
Temperate cDNA synthesis kit (Agilent technologies) according to the manufacturer’s instructions.   
The qPCR experiments in this project utilised TaqMan (Applied Biosystems) chemistry and were 
performed in a MicroAmp Optical 96 well plate (Applied Biosystems) on a StepOnePlus real-time PCR 
machine (Applied Biosystems) with each well containing 1ul TaqMan primer-probe (all primers were 
exon-spanning), 1ul cDNA, 10ul Mastermix and 8ul RNase free water.. Triplicate technical replicates 
were performed for each experiment with GAPDH serving as the housekeeping control.   
Statistical analysis 
 Statistical analysis was performed using Prism software version 5.0 (Graph Pad Software, San Diego, 
USA). Parametric data was assessed by Student’s t-test or one way ANOVA. Statistical significance 
was defined as a p-value of 0.05 or less. All error bars represent the standard error of the mean 
(SEM). Non-parametric data was analysed by the Kruskall-Wallis test. 
 
Results 
Senescence and plasticity markers in human liver transplant biopsies 
Triple colour immunohistochemistry of transplant biopsies and time zero controls were scored and 
are shown in Figure 1, panels A-E. S100A4 cells (red) are clearly delineated, as is the strong nuclear 
positivity of p21WAF1/Cip (black), allowing co-localisation with the BEC specific CK19 (brown). 
p21
WAF1/Cip
 positive cells indicated senescence and those positive for S100A4 indicated de-
differentiation/presence of cellular plasticity. During assessment, dual positive S100A4 and 
p21
WAF1/Cip1
 positive biliary epithelial cells were not seen. Also, there were few examples of adjacent 
p21
WAF1/Cip1 
and S100A4 positive BEC. Blue arrows indicate infiltrating S100A4 positive cells, black 
arrows show BEC stained with either S100A4 or p21.  
Analysis showed significant increase of p21
WAF1/Cip1
 (p=0.034) and S100A4 (p=0.0068) positivity per 
bile duct with increasing grades of acute cellular rejection (Figure 1, panels F, G). Using the 
Spearman correlation test it was demonstrated that there was a statistically significant correlation 
(p=0.0013) between the expression of S100A4 and p21
WAF1/Cip1
 (Figure 1, panel H). 
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As previously described(20)  p21
WAF1/Cip1
 alone is not a specific marker for senescence, though it is 
much more specific when described in Ki67 negative cells. In line with the published literature(20, 
21) the presence of Ki67 negative/γH2AX positive cells is regarded as the gold standard for 
senescence detection. To define whether there was further evidence of senescence in ACR; biopsies 
were also stained for Ki67 and γH2AX. γH2AX positivity was defined by the presence of more than 5 
positive foci per nucleus. Cells positive for γH2AX (and negative for Ki67) were seen with increasing 
frequency (Figure 2 panels I-K) in cases with increasing ACR grade. For completeness dual staining of 
Ki67 and p21
WAF1/Cip1
 was performed (Figure 2 panels L-N). This showed that Ki67 negative 
p21
WAF1/Cip1
 positive cells were present. Enhanced production of reactive oxygen species is another 
component of the senescent phenotype, leading to accumulation of autofluorescent, lipofuscin-like 
material (Passos et al. 2010). BEC in ACR show greatly enhanced autofluorescence (supplementary 
Fig S3). 
Proliferation and plasticity markers in human liver transplant biopsies 
Triple colour immunohistochemistry was performed for the markers Ki67 (black), S100A4 (red) and 
CK19 (brown) (Figure 2 panels A-C). As previously reported in the literature there was an increase in 
the Ki67 positive cells with increasing grade of rejection. 80-85% of the Ki67 positive cells in 
moderate or severe rejection were also co-stained with S100A4; those that were not co-stained 
were adjacent to S100A4 positive BEC. The majority of S100A4 positive BEC were not dual stained 
for Ki67 as shown in panel C. Figure 2 Panels D-H show images of biopsies from transplant recipients 
with biliary anastomotic stenosis or obstruction. Stains are p21
WAF1/Cip 
(black), S100A4 (red) and CK19 
(brown). 
Oxidative stress-induced senescence in BEC cultures 
Following treatment by H2O2 immortalised BEC were assessed for senescence by detection of 
nuclear p21
WAF1/Cip1
 expression as this is related to cell cycle arrest and senescence(22). The numbers 
of positive nuclei per high power field (x20 lens; LSCM) were counted, with one field from each of 
the triplicate of experiments included in the analysis. Treatment with H2O2 at 200µM for 2 hours 
produced significant nuclear expression of p21
WAF1/Cip1
 after 48 or 72 hours, consistent with the 
literature.  
Peak p21
WAF1/Cip1
 expression was after 48 hours, with a rapid decline after this time (Figure 3 panels 
A-E). This was assessed by one way ANOVA  p<0.0001. Post hoc t-tests showed that control versus 
48 and 72 hours were significant at p<0.001. The rise in expression between 24, 48 and 72 hours 
were all significant at p<0.001. Comparable findings were demonstrated using primary BEC, where 
untreated cells showed no expression of p21
WAF1/Cip1
, 200µM hydrogen peroxide gave a rapid up 
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regulation in nuclear p21
WAF1/Cip1
 at 48 hours with down regulation after 72 hours (inset images 
Figure 3 panels A and C).  
Oxidative stress- induced epithelial de-differentiation in BEC cultures 
Immortalised BEC showed a morphological change 72 h after exposure to H2O2 from typical 
cobblestone to spindle cell morphology with increased expression of S100A4, a marker of de-
differentiation (Figure 4 panels A-E).  This morphology was consistent with the de-differentiation 
seen when immortalised BEC cells are exposed to TGF-β1 (23). Triplicate cultures of immortalised 
BEC were exposed to 200µΜ H2O2 for two hours followed by incubation for 24, 48, 72, 96 or 120 
hours. To control for potential tissue culture induced changes, triplicate cultures were plated and 
incubated for the same length of time as the treated cultures, with no change in morphology of 
expression. At all time-points, cultures were stained for αSMA (Figure 4 panels K-O), S100A4 (Figure 
4 panels A-E), fibronectin, Vimentin and ZO-1 (Figure 4 panels F-J). In all cases, the secondary 
antibody was FITC-conjugated (green fluorescence, Figure 4). Densitometric analysis was performed 
to quantify changes in antigen expression. This involved assessment of a defined area of each Z 
series obtained, one field from each of the three cultures. These data are presented in Figure 4 
panels P-R. For each antigen a one-way ANOVA was performed, showing statistical difference in the 
expression of S100A4 (p=0.0096), αSMA (p=0.0348) and ZO-1 (p=0.0018). Post-hoc t tests 
demonstrated that αSMA expression was significantly increased at 48 hours compared to control 
and also increased between 24 and 48 hours. ZO-1 expression was significantly decreased at 24, 48 
and 120 hours versus control. 
Further data from the time points of maximum expression of αSMA and S100A4 (48 and 72 hours) 
showed an increase in expression of ECM components fibronectin (p=0.0176) and Vimentin 
(p<0.0001) (Figure 5 panels A-F, H and I). In order to provide further support for this change in 
antigen expression, cell lysates were separated by SDS-PAGE and the membranes probed using the 
same antibodies. These showed expression of fibronectin (at correct molecular weight, Figure 5 
panel G) that increased from baseline, peaking at 48-72 hours. Following all other experiments the 
cells that had been passaged were stained for the epithelial markers in order to verify that the 
immortalised BEC cell lines had retained their epithelial characteristics. These cells exhibited strong 
baseline staining for CK19 and E-cadherin (supplementary data Figure 1).    
Oxidative stress-induced de-differentiation of cultured BEC is TGF-β dependent 
To determine whether the observed de-differentiation in immortalised BEC was due TGF-β 
signalling, cell culture medium from peroxide treated immortalised BEC was retained to perform 
TGF-β ELISA. Following acid treatment to permit total TGF-β to be detected, these media were 
Page 35 of 64
ScholarOne support: (434) 964 4100
American Journal of Transplantation
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
IN SUBMISSION
12 
 
assayed in triplicate against controls. These data demonstrated TGF-β1 levels to be not significantly 
raised; whereas TGF-β2 levels were raised significantly over time (p = 0.006, Figure 6).   
In order to demonstrate causality in this in vitro system, a triplicate culture of immortalised BEC was 
incubated with a TGF-β type 1 receptor serine/threonine kinase (ALK5) inhibitor (SB-505124) at an 
optimal concentration of 1µΜ (data not shown), for one hour before exposure to 200µΜ H2O2 for 
two hours followed by incubation for a further 72 hours before staining for the antigens S100A4, ZO-
1, p21 and αSMA (Figure 7 Panels A-F). Densitometric analysis was performed as above (Figure 7 
panels G and H). The increased expression of S100A4 and αSMA and the decrease in ZO-1 normally 
produced by H2O2 exposure were almost completely abrogated by inhibition of TGF-β signalling. 
Statistical analysis between the SB-505124 treated and untreated, H2O2 exposed groups at 72 hours, 
by two-way ANOVA was positive at p < 0.0001.     
TGF-β and p21WAF1/Cip1 RNA Expression in BEC cultures 
Both immortalised and primary BEC were assessed for the expression of mRNA encoding p21
WAF1/Cip1
, 
TGF-β1 and TGF-β2. Figure 8 demonstrates a clear increase in p21
WAF1/Cip1
 expression (panel A) 
peaking at 12 hours after treatment with H2O2 before falling back to baseline by 24 hours. TGF-β1 
showed a slight increase at 12 hours whereas TGF-β 2 showed a significant 6 fold increase (Figure 8 
panel C) at 4 hours which was sustained, falling back to near baseline by 24 hours. To determine if 
the observed expression of p21
WAF1/Cip1 
in primary BEC was also associated with TGF-β expression, 
primary BEC were either untreated or treated with 200µM hydrogen peroxide and incubated for 6 or 
12 hours from initial exposure and treated as the immortalised BEC. The primary cells also showed 
an increase in p21
WAF1/Cip1
 (Figure 8 panel D) and TGF-β2 expression (Figure 8 panel F) at 6 hours 
followed by a fall back to baseline by 12 hours. There was only a decrease in TGF-β1 expression 
(Figure 8 panel E). 
 
 
Activation of TGF-β by BEC 
In order to assess the potential of BEC to activate latent TGF-β, immortalised BEC cultures were 
assessed for their ability to up regulate β6 integrin. Immortalised BEC were either used without 
treatment or following 200µM H2O2 for 2 hours and incubation for 24 or 48 hours. At baseline 
expression of β6 integrin was not present; there was a significant up regulation in response to 
oxidative stress (P<0.001; supplementary figure 2). 
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Discussion 
This study suggests that cellular senescence plays a key role in acute cellular rejection of liver 
allografts. A clear positive correlation was demonstrated between the number of p21
WAF1/Cip1
 positive 
biliary epithelial cells and increasing grade of acute rejection.  This is consistent with data from other 
groups detailing severity in chronic cholestatic liver diseases (10, 13, 16). In addition to its role as a 
marker of senescence, p21
WAF1/Cip1
 can also be upregulated during the G1 phase of the cell cycle(24).  
Ki67 is a marker of proliferation present throughout all active phases of the cell cycle (25). In order 
to differentiate senescent and proliferating cells, Ki67 was used in a triple label in place of 
p21
WAF1/Cip1
. This demonstrated that Ki67 and p21
WAF1/Cip1
 positive BEC occupy different cellular 
niches. Whereas p21
WAF1/Cip1
 positive cells never co-stained for S100A4 and were never seen adjacent 
to S100A4 stained BEC, Ki67 stained cells were always either co-stained for S100A4 or adjacent to 
S100A4 positive BEC in moderate to severe rejection (though in mild rejection Ki67 positive cells 
were seen in the absence of S100A4). These results are compatible with a model in which the BEC 
that express p21
WAF1/Cip1
 are non-proliferating, senescent cells whilst other BEC, which may also 
express S100A4, are actively proliferating. The presence of the senescence marker γH2AX was also 
assessed, this being regarded as a gold standard for the assessment of senescence(20). In sections of 
ACR; Ki67 negative, γH2AX positive cells were identified with increasing frequency in line with 
increasing Banff grade. This would strongly suggest that senescent cells are indeed present in 
increasing number with increased Banff grade, in line with our observations of p21
WAF1/Cip1
. The dual 
staining of p21
WAF1/Cip1 
and Ki67 was also performed, showing the presence of Ki67 negative 
p21
WAF1/Cip1
 positive cells in ACR. 
An in vitro model was established to investigate the possible link between senescence and epithelial 
de-differentiation. This initially aimed to replicate the findings of Nakanuma et al (8, 14), before 
evaluating the SASP in relation to epithelial plasticity. Transient increases in p21
WAF1/Cip1
 expression 
by both immortalised and primary BEC were observed after oxidative stress. Staining for further 
antigens also revealed that immortalised BEC spontaneously underwent de-differentiation following 
peroxide exposure. This is consistent with observations reported previously for respiratory 
epithelium (26, 27). The phenotype of the primary and immortalized BEC differed in that primary 
BEC retained their CK19 expression more than immortalised BEC and also retained a more epithelial 
morphology at respective time points. This may be due to the immortalisation process or the 
presence of a collagen rich scaffold(28), therefore caution must be taken in extrapolating the 
proteomic results from the in vitro to in vivo environments. 
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Several groups have studied factors that may drive epithelial de-differentiation downstream of TGF-
β, including Sonic Hedgehog(29-31) and Jagged/Notch(32) (e.g.). However, the factor or factors 
driving oxidative stress-induced epithelial de-differentiation have not been defined. While the 
expression of chemokines and interleukins has been studied in relation to the SASP in BEC, the 
expression of TGF-β has not (8, 33). Passos (34) described a putative pathway in fibroblasts 
undergoing replicative senescence and expressing p21
WAF1/Cip1
 that would increase the expression of 
TGF-β receptors and the TGF-β2 isoform. To evaluate this, total TGF-β was quantified from the cell 
culture medium of two time-course experiments using ELISAs specific for TGF-β1 and TGF-β2. These 
assays showed a slight decrease in total TGF-β1 expression but a four-fold increase in total TGF-β2. 
To support that this was indeed the mechanism producing the observed de-differentiation, the ALK-
5 (TGF-β type I) receptor was blocked using a specific and non-toxic pharmacological inhibitor SB 
505124(35). This inhibitor prevented the observed de-differentiation changes normally produced in 
response to peroxide. This is consistent with the described differential expression of TGF-β1 and β2 
transcripts in rodent and human liver fibrosis (36) with a restriction of TGF-β2 transcripts to the 
biliary epithelium.  
To demonstrate that the expression of p21
WAF1/Cip1 
and TGF-β was due to increased transcription, 
qPCR of isolates from both immortalised and primary BEC were performed. This showed that there 
was indeed a transient increase in transcripts for p21
WAF1/Cip1
 and TGF-β2 in both cell types. One of 
the potential confounding factors of using the immortalised BEC is interruption of the p53 signaling 
pathway by the SV40 large T antigen, the agent used in immortalising these cells(37). However, it 
was shown that up regulation of both p21
WAF1/Cip1
 and TGF-β2 is independent of any action of SV40 
as similar expression profiles were produced by the same stimulus in both immortalised and primary 
BEC. However, a difference in the kinetics of this up-regulation was observed, with primary BEC 
showing increases at earlier time points than immortalised BEC. This is likely due to the stabilizing 
effects of SV40 on p21
WAF1/Cip1
 expression, as this is a downstream effecter of p53(38). Ultimately the 
profiles of gene expression in these cells are comparable within this system and serve to support the 
use of immortalised BEC as an appropriate model.  
TGF-β is produced initially as a pro-protein which is cleaved by furin-like proteases to yield a small 
latent complex consisting of dimeric TGF-β which is concealed by two Latency Associated Peptides 
(LAP), This inactive complex can be activated by interaction with the αvβ6 integrin(39-41) which can 
bind an RGD motif on the LAP leading to a conformational change. The current study showed that 
resting BEC did not express the β6 integrin, but this was induced following exposure to oxidative 
stress potentially allowing these cells to activate latent TGF-β.   
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It has already been shown that expression of markers of proliferation in BEC correlates with Banff 
grade(25, 42). p21
WAF1/Cip1
 can be up regulated as a consequence of cell cycle regulation, replicative 
senescence (associated with telomere shortening) or as a result of oxidative stress and other cell 
damage (e.g. p53 mediated) pathways(22). Acute injurious stimuli can, therefore, lead to senescence 
in the biliary epithelium, which causes an up-regulation in p21
WAF1/Cip1
. This triggers chemokine and 
TGF-β2 production, which may drive disease progression. In vitro this is observed as de-
differentiation in response to TGF-β2. This response is also seen in primary BEC indicating that this is 
highly likely to model the in vivo response of the biliary epithelial compartment to injury. The 
presence of senescent BEC in ACR may suggest a link between acute and chronic rejection. 
Senescent BEC are a well described feature of chronic ductopaenic rejection(43) and as the number 
of senescent cells correlates with Banff grade(44), so does the probability of future chronic rejection. 
Chronic rejection has changed, most likely modified by newer anti-rejection agents, the underlying 
biology of which is not currently understood. Expression of TGF-β subtypes by the biliary epithelium 
also has the potential to modify the immune system, with a likely increase in regulatory T cells as 
well as a promotion of wound healing/fibrosis  
We have provided observational evidence of intermediate “plastic” cell types in the bile ducts of 
human liver biopsies undergoing acute rejection. As a marker of plasticity, it must be remembered 
that S100A4 is also present in certain normal cell types including macrophages(45) and in the cells of 
the peribiliary glands(46). Expression of S100A4 has been clearly shown in BEC in the finer branches 
of the biliary tree and anatomically distinct from the peribiliary glands which are preferentially 
associated with the intrahepatic large bile ducts. In replicating these findings in vitro, we have 
observed de-differentiation, driven by TGF-β2. Interestingly the response of the immortalised BEC to 
oxidative stress was to adopt a CK19-, ZO-1-, S100A4+, αSMA+ phenotype and an irregular, stellate 
morphology. These cells therefore exhibited some characteristics of myofibroblasts and activated 
Hepatic Stellate Cells (HSC) (15).  Any potential role for these stellate-like biliary epithelial cells in 
vivo is however uncertain.  
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Figure legends: 
Figure 1: Triple colour immunohistochemistry of senescence and plasticity 
markers in human liver transplant biopsies. Panels A-E represent photomicrographs 
depicting the relative staining attained using the three colour technique. Brown staining reflects 
CK19 expression, Black p21
WAF1/Cip 
and red S100A4. Cells staining dual positive for S100A4 and CK19 
are shown with black arrows. Infiltrating cells (blue arrow) were excluded morphologically or with 
reference to further immunohistochemistry. Panel A represents a time zero biopsy, used as control.  
Panel B and C mild acute cellular rejection and panels D and E moderate and severe ACR 
respectively. Inset image shows section stained with no primary antibody. Panels F-H show graphs 
attained by scoring the biopsies. Panel F indicates the number of S100A4 positive biliary epithelial 
cells per bile duct, with a clear increase with increasing grade of acute cellular rejection. Panel G 
indicates the same association with S100A4 p21
WAF1/Cip
 expression and Panel H Shows the correlation 
between S100A4 and p21 expression. 
Figure 2: Triple colour immunohistochemistry of proliferation markers 
and control human transplant biopsies. Panels A-C represent Transplant biopsies 
stained for Ki67 (black), S100A4 (red) and CK19 (brown). Panels A demonstrates mild rejection and 
Ki67 positive BEC are clearly seen in the absence of S100A4. Panel B shows Ki67 and S100A4 dual 
positive BEC in moderate rejection, with the spatial relationship between single positive S100A4 or 
Ki67 positive BEC apparent. Panel C Shows a field from a severe rejection biopsy, indicating the 
number of S100A4 positive BEC relative to Ki67 positive BEC. Panels D-H Represent fields from 
human liver transplant recipients with biliary anastomosis obstruction or stricturing. These are 
stained with p21
WAF1/Cip 
(black), S100A4 (red) and Ck19 (brown) as control material. The abundance 
of staining for all antigens is apparent. Panels I – K show dual staining for Ki67 (brown) and γH2AX 
(black) Panel I shows ACR biopsy material, the main image is a negative control, the inset image is a 
single stained γH2AX, showing the characteristic punctate nuclear staining pattern. Panel J is from a 
moderate ACR biopsy, clear Ki67 negative and γH2AX positive cells are seen. Panel K shows a severe 
ACR biopsy with a clear increase in the numbers of Ki67 negative and γH2AX positive cells. Panels L-N 
show dual stained Ki67 (brown, brown arrows) and p21
WAF1/Cip1 
(black, black arrows). Panel L is from 
a mild ACR showing only Ki67 positivity, Panel M is moderate and panel N severe ACR. 
Figure 3: Photomicrographs demonstrating p21WAF1/Cip expression. The nuclei 
of the Immortalised BEC are visualised with DAPI and are blue.  p21
WAF1/Cip 
is stained with FITC and is 
green. Panels A, B, C, D and E show results observed at time 0, 24, 48, 72 and 120 hours respectively. 
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The increase in nuclear p21
WAF1/Cip
 staining is seen with a peak at 48 hours. Staining seen at 72 hours 
is largely cytoplasmic, indicating phosphorylated and therefore inactive p21
WAF1/Cip
. The nuclear 
staining is shown graphically in panel F, 3 representative fields from 3 separate experiments at each 
time point. Primary BEC were also stained, images are shown inset for control (inset A) and at 48 
hours (inset C).   
Figure 4: Photomicrographs depicting change in antigen expression over 
time. Each photomicrograph is a representative sample from triplicate experiments. The incubation 
period post peroxide exposure is noted along the top. Panels A-E show the change in S100A4 
expression, F-J the change in ZO-1 expression and K-O the change in α-SMA expression. Significant 
changes in morphology can be seen, with spindle cell morphology apparent  after 48 hours. For each 
of the antigens ZO-1, α-SMA and S100A4, densitometric analysis was performed as described in 
methods. The results are tabulated in panels P-R, based on triplicate readings with the mean and 
standard error shown. Clear changes in expression of the antigens are seen, with increasing S100A4 
and α-SMA and decreasing ZO-1 expression statistically significant (one way ANOVA) at p = 0.0096 
(S100A4), aSMA at p = 0.0068 and ZO-1 at 0.0087.  
 
Figure 5: Extracellular matrix expression. The expression of extracellular matrix 
components was assessed by fluorescence microscopy and confirmed by western blot. The 
expression of Vimentin (panels A-C) and Fibronectin (panels D-F) is clearly absent at baseline but is 
apparent at 48 and 72 hours post peroxide exposure. The fluorescence was quantified by 
densitometry and data shown in panels H and I (significant after 72 hours at p = 0.0273 and p = 
0.0241 respectively). Cell lysates from all time points are shown, following separation by SDS-PAGE 
(Panel G), and also show a significant increase in fibronectin expression. 
Figure 6: TGF-β ELISA. Two ELISAs were performed to assess total TGF-β expression. The level 
of TGF-β1 (panel A) appears largely constant but the expression of TGF-β2 (panel B) shows almost a 
four-fold increase between time 0 and 72 hours (P = 0.0058), where it appears to plateau before 
falling sharply.   
Figure 7: TGF-β receptor blockade. Panels A-C show antigen expression at 72 hours post 
H2O2 exposure as seen in Figure 3. Panels D-F show antigen expression of immortalised BEC cells 
that were treated with the ALK-5 inhibitor SB-505124 at 1µM for 1 hour before H2O2 exposure and 
incubation for 72 hours; no induction of αSMA or S100A4 was observed whilst ZO-1 expression was 
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retained. Densitometric analysis is presented in panels G and H; two way ANOVA shows statistical 
significance at p<0.0001. 
Figure 8: qPCR of immortalised and primary BEC. Graphs shown represent triplicate 
replicates of representative qPCR experiments. Panels A-C show expression of mRNA in 
immortalised BEC cells at time points after exposure to 200µM H2O2. Panels D-F show expression of 
mRNA in primary BEC at time points after 200µM H2O2 exposure. One way ANOVA showed 
p21
WAF1/Cip 
expression to be significant at p < 0.001 (immortalised BEC) and p = 0.0285 (primary BEC) 
and TGF-β2 expression to be significant at p < 0.001 (immortalised BEC) and p = 0.042 (primary BEC) 
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Materials and methods 
Ethics 
Ethical approval was obtained from a local regional ethics committee for the use of patient samples. 
Samples represented excess liver tissue that had been taken for diagnostic purposes; each sample 
was identified by means of a number allocated by the Cellular Pathology department. Approval 
reference REC 06/Q0905/150 Amendment 1; date of amendment 09/01/2007 by the Newcastle and 
North Tyneside Local Research Ethics Committee 1 
Immunohistochemical (IHC) triple staining of human liver biopsies  
Paraffin embedded tissue sections were de-waxed by incubation in xylene for 10 minutes and 
rehydrated by 1 minute washes in 100% and 95% ethanol. To reduce endogenous peroxide activity, 
sections were incubated in 0.2% hydrogen peroxide in methanol for 10 minutes at room 
temperature (RT). Antigen retrieval was achieved by pressure cooking (heat-induced antigen 
retrieval) for 1min in EDTA buffer pH 8 – 9. Several biotinylated secondary antibodies were used; 
endogenous biotin in the tissue was blocked using a biotin-avidin kit (Vector). Following washing in 
Tris-buffered saline (TBS pH7.6), sections were incubated in 20% normal swine serum (in TBS) for 1 
hour at RT; to reduce non-specific antibody binding. Primary antibody was then added (anti-
p21
WAF1/Cip1 
(Santa Cruz) 1:50 or anti-CD3 (DAKO) 1:100) in 20% normal swine serum at 4˚C overnight 
in a humidified chamber. After washing in TBS, biotinylated goat anti-mouse IgG (Vector, 1:200) in 
20% normal swine serum was added for 1 hour at 22˚C. Sections were then washed in TBS and 
developed with the Vector ABC (peroxide) kit according to the manufacturer’s instructions. The first 
stage was developed with Nickel 3,3’ diaminobenzidine tetrahydochloride  (NiDAB), giving a black 
colour. Following washing in running tap water then TBS the samples were incubated with a mix of 
anti-Cytokeratin 19 (DAKO; 1:1000) and anti S100A4 (BD, 1:200) in 20% normal swine serum at 4˚C 
overnight in a humidified chamber. A further wash with TBS followed by incubation with peroxidase 
conjugated horse anti-mouse IgG (Vector; 1:100) in 20% normal swine serum for 1 hour at 22˚C.  This 
was then developed with 3, 3’ diaminobenzidine tetrahydochloride (DAB) producing a brown colour 
where CK19 was detected. A further secondary antibody was subsequently added; biotinylated goat 
anti-rabbit IgG (Vector; 1:200) in 20% normal swine serum for 1 hour at RT. This was developed with 
the Vector ABC-AP kit according to the manufacturer’s instructions. The final development was with 
Vector red in Tris-HCl buffer, pH 8.2-8.4, for 10 min. This gave a red colour where the presence of 
S100A4 was seen. A light counterstain was added with Mayer’s haematoxylin before dehydration in 
an ethanol series (70%, 90%, 95% and 100%) and mounting with DPX. 
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Analysis 
The cases represented 9 time zero biopsies (tissue taken at the point of reperfusion of a 
transplanted liver) as control tissue and 25 biopsies of transplanted liver with varying grades of acute 
rejection (mild, moderate and severe). The sections obtained were stained with one set of three 
antibodies; either p21
WAF1/Cip1
, CK19 and S100A4 or CD3, CK19 and S100A4. Complete triple labelled 
sections were scanned using an Aperio slide scanner at x20 and remotely accessed files were 
analyzed. Each biopsy was assessed by two observers (JGB and HR) and scored for number of portal 
tracts, number of bile duct radicles, maximum number of bile ducts per portal tract, number of 
p21
WAF1/Cip1
 positive BEC, number of S100A4 BEC, number of dual stained BEC (S100A4 and 
p21
WAF1/Cip1
) and number of p21
WAF1/Cip1
 and S100A4 BEC adjacent to one another. There was good 
agreement between the observers, any discrepancies were noted and a consensus opinion reached. 
As a number of immune cells stain positive for S100A4, there was a chance that infiltrating 
macrophages or T cells could be mistaken for BEC. This was usually straightforward to assess 
morphologically. Serial CD3 stained sections allowed some assessment of T cell mediated EMT. 
Cell culture 
The H69 cell line was created by Grubman [9] from human intrahepatic BEC. These cells exhibit 
characteristics of normal human biliary epithelium, with expression of CK7 and 19. The H69 cells 
were cultured in 25cm
2 
or 75cm
2 
flasks in a mix of Dulbecco’s Modified Eagle’s medium and Nutrient 
Mixture F12 Ham (3:1) (Sigma) supplemented with: 1.8 x 10
-4
M adenine (24.3mg/l) (Sigma), 2 x 10
-
9
M triiodothyronine (1.345μg/l) (Sigma), 5.5 x 10
-6
M epinephrine (1.0mg/l) (Sigma), ITS-X 
supplement (10mg/l insulin, 5.5g/l transferring, 2.0g/l ethanolamine, 6.7μg/l sodium selenite) 
(Gibco, Invitrogen), 1μM hydrocortisone solution (362.46μg/l) (Sigma), 10% Heat inactivated FCS 
(Sigma) and PenStrep (100U/ml of penicillin and streptomycin) (Sigma)  
Primary biliary epithelial cells were isolated from human explanted livers as described and were 
cultured on plasticware coated with rat tail collagen. Culture medium composed: DMEM 
(Invitrogen), Hams F12 (Sigma-Aldrich), 10% human serum (HD Supplies), EGF (10ng/ml, Peprotech), 
HGF (10ng/ml, Peprotech), hydrocortisone (2mg/ml Sigma-Aldrich), Insulin (0.124U/ml, Sigma-
Aldrich) tri-iodo-thyronine (2nM/ml Sigma-Aldrich), cholera toxin (10ng/ml Sigma-Aldrich), L-
glutamine (2mM Gibco), Penicillin (100U/ml Gibco), streptomycin (100ug/ml Gibco).  
Immunofluorescence and densitometry 
For immunofluorescence experiments, H69 BEC were seeded on glass 8-chamber slides (Becton 
Dickinson, UK) at 50,000 cells per chamber with 250µl of culture medium. Cells were cultured for 24-
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48h until a confluent monolayer was formed. Following optimisation, cells were subjected to 
oxidative stress by the addition 200µM hydrogen peroxide (final concentration) for 2 hours followed 
by rinsing in PBS and addition of fresh culture medium. After a preset time (24, 48, 72, 96 or 120 
Hours) the cells were rinsed with PBS, fixed with 4% phosphate-buffered paraformaldehyde (30min 
at 22ºC) and permeabilised with 0.1% Triton X-100 in PBS (15min at 22°C). Cells were then incubated 
(at 22ºC) with 5% BSA in PBS for 90 minutes to minimize non-specific antibody binding. At this stage 
the chamber structure was removed from slides. 
Primary antibodies specific for S100A4 (DAKO, 1:100), αSMA (Sigma, 1:100), E-cadherin (BD 
Biosciences, 1:50), ZO-1 (Invitrogen, 1:100), p21
WAF1/Cip1
 (Santa Cruz 1:100), Fibronectin (Sigma 1:100) 
or Vimentin (DAKO 1:100) were added in 5% BSA for 48 hours at 4°C. For each time point and 
antigen a no-primary antibody treated preparation and a non-specific isotype/species specific 
primary antibody preparation were used as negative controls. The cells were then washed with 0.1% 
Tween-20 in PBS prior to addition of  FITC- conjugated anti-mouse or anti-rabbit (DAKO, 1:100) 
secondary antibody in 5% BSA for 48h at 4
O
C in the dark. Following washing in PBS the slides were 
stained with DAPI in PBS (at a concentration of 1µg/ml) for 10min at 22OC. The slides were then 
washed in PBS and mounted in fluorescence mounting medium (DAKO). Storage was at 4
O
C.   
Visualisation was by immunofluorescence using a Leica TCS SP2 UV laser-scanning confocal 
microscope (LSCM) for the chromogens: FITC (excitation 488nm, emission 510-535nm) and DAPI 
(excitation 345nm, emission 450-550nm). Emission levels were set against a control section. 
Representative z series were taken of each section/specimen and used for densitometric and 
morphological analysis. Densitometry analysis was by LCS software. All experiments were conducted 
in triplicate.  
Western blotting 
Protein lysate preparation  
H69 growing in 75cm
2 
flasks were rinsed with PBS and drained. 100µl of lysis buffer (Phosphosafe™ 
Merck KGaA, Darmstadt, Germany) was applied and the cells were scraped off with a cell scraper. 
The contents of the flasks were then pipetted into centrifuge tubes and then sonnicated for 10 
seconds; this was followed by centrifugation at 200g. Supernatant was aliquoted into fresh 
centrifuge tubes and frozen at -80
O
C. Supernatant Total protein concentration was estimated with a 
BCA protein assay kit (Pierce, USA). This allowed production of a standard curve for absorbance at 
562nm. Extracts were then stored at -20
O
C.  
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For use in SDS-PAGE; samples were thawed and supplemented with 10% β-mercaptoethanol and 4x 
NuPAGE sample buffer (Invitrogen). Samples were boiled for 10 minutes, allowed to cool, and then 
added to SDS-PAGE gels.    
 
 SDS-Polyacrylamide electrophoresis and Western blotting  
20µg of total protein lysate per well was separated by 4-12% gradient Sodium-dodecyl sulphate 
Polyacrylamide gel electrophoresis (SDS-PAGE). Separation was carried out using stable voltage, 
(20V per gel). Separated proteins were transferred from the gel to Hybond-P nitrocellulose 
membrane (Amersham Pharmacia Biotech, UK) overnight at 50mA. Non-specific antibody binding 
sites on the membrane were blocked with 5% skimmed milk in TBS for 90 minutes. Primary 
antibodies were diluted in 5% milk/TBS to optimal concentrations. The membranes were incubated 
with primary antibodies overnight at 4
O
C and washed several times with TTBS (TBS supplemented 
with 0.1% Tween-20).  Membranes were then incubated with secondary antibodies conjugated with 
HRP (Horse Radish Peroxidase) for 1h at RT. After washing with TTBS, the membrane was developed 
using Pierce Pico Chemiluminescence kit (Pierce). Visualisation was by use of G-Box CCD camera ().  
Following development, membranes were washed and stripped of antibodies by incubation with 
stripping buffer (62.5M Tris, 2% SDS, 100mM β-mercaptoethanol, pH 6.8) at 60
O
C for 30 minutes. 
Membranes remained in the cooling buffer with agitation for a further 30 minutes. Membranes 
were washed in TTBS, re-blocked in 5% skimmed milk for 90 minutes and incubated overnight at 4
O
C 
with anti-β-tubulin antibody (Sigma 1:5000) in 5% skimmed milk and TBS. Secondary antibody was 
anti-rabbit HRP conjugated antibodies (Sigma 1:5000) with development as for primary antibodies. 
The intensity of β-tubulin was used to validate equal loading.   
ELISAs 
ELISA kits specific for the TGF-β1 and TGF-β2 isoforms were purchased from R&D Systems (UK). Cell 
culture medium from two separate time courses was retained for analysis. This was first treated with 
acid (50µl 6M HCl per ml medium for 10 minutes followed by neutralisation with 50µl per ml of 6M 
NaOH) in order to assess the total rather than the active amount of TGF-β. The kits were then used 
in accordance with the manufacturer’s instructions.   
Real-time Quantitative Polymerase Chain Reaction (qPCR)  
All experiments carried out for qPCR including RNA isolation and cDNA synthesis were done in an 
RNase free environment to minimise the risk of contamination.  RNA isolation was performed 
according to the method developed by Chomczynski and Sacchi. The method utilises TRIzol reagent 
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(Sigma) a mono-phasic solution of phenol and isothiocyanate to extract total RNA from cells. Cells 
grown in T75cm2 flasks were re-suspended in 1ml TRIzol RT for 5min to allow TRIzol to disrupt and 
dissolve cellular components whilst maintaining RNA integrity. The addition of chloroform (200 
μl;10mins; RT) followed by centrifugation (12000xg; 15min; 4
O
C) causes the solution to separate into 
two phases; a lower (organic) phase containing DNA and protein and the upper aqueous phase 
containing RNA. This upper phase was transferred into a new eppendorf with isopropanol 
added(0.5ml; 10min; RT) to precipitate the RNA followed by centrifugation (12000xg;10min;4
O
C). 
The supernatant was removed and the RNA pellet washed with ethanol (1ml;75%) and centrifuged 
(7500xg; 4min; 4
O
C). The supernatant is again removed and the pellet air dried before re-suspended 
in 50μL of RNase-free water. The RNA is quantified and quality assessed using a nanodrop 
spectrophotometer (NanoDrop ND-1000, Thermo scientific, Wilmington USA.), 
First Strand cDNA synthesis  
Isolated RNA is reverse transcribed to cDNA using an AffinityScript Multi Temperate cDNA synthesis 
kit (Agilent technologies). The reverse transcriptase enzyme utilised in the kit is a genetically 
engineered version of MMLV reverse transcriptase that has improved specific activity over a broad 
range of temperature from 42
O
C to 55
O
C. The kit can deliver high yields of cDNA from small amounts 
of RNA (1ng-5ug). In this project, where possible, 5μg of RNA was used per reaction and 3μl of 
random hexamers were used instead of oligo-dt primers to ensure correct synthesis. The subsequent 
steps were performed as per manufacturer’s instructions. cDNA was stored at -20
O
C until PCR was 
performed.  
Real-time Quantitative Polymerase Chain Reaction  
qPCR was performed to quantify altered gene expression by amplifying a targeted cDNA molecule. 
qPCR utilises the same basic method as traditional PCR but qPCR uses fluorogenic probes to allow 
monitoring of the reaction in ‘real-time’ throughout all three phases; exponential, linear and 
plateau. Traditional PCR measures only during the plateau phase, with the product visualised as a 
band on agarose gel detecting only the presence of the target gene, however, qPCR measures during 
all phases thus allowing for accurate quantitation of target sequence levels, Figure 7 &Table 3. 
The qPCR experiments in this project utilised TaqMan (Applied Biosystems) chemistry and 
SYBRgreen chemistry in the gene array described below. TaqMan uses a fluorogenic probe to 
guarantee specific hybridisation between probe and target gene sequence. The probe is designed 
with a reporter high-energy dye at the 5’ end and low energy quencher dye at the 3’ end, Figure 8 
qPCR was performed in a MicroAmp Optical 96 well plate (Applied Biosystems) on the StepOnePlus 
real-time PCR machine (Applied Biosystems)with each well containing 1ul TaqMan primer-probe, 1ul 
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cDNA, 10ul Mastermix and 8ul RNase free water. The primers used were exon-spanning minimising 
problems associated with genomic DNA contamination. The mastermix used contained ROX, a 
fluorescent dye that provides an internal reference for the reporter dye to be normalised against 
therefore minimising complications associated with inter-well error. For each primer triplicate 
technical replicates were performed and a negative control was included that contained no 
template. To quantify the relative gene expression a gene of interest cycle threshold (Ct) value is 
compared against a housekeeping gene Ct e.g. GAPDH by the formula as described by Yuan et al(55) 
giving rise to the corresponding ΔΔCt and fold change values 
Statistical analysis 
 Statistical analysis was performed using Prism software version 3.0 (Graph Pad Software, San Diego, 
USA). Parametric data was assessed by Student’s t-test or one way ANOVA, depending on the 
number of groups and parameters to compare. Statistical significance was defined as a p-value of 
0.05 or less. All error bars represent the standard error of the mean (SEM). If a significant result was 
obtained then post hoc t tests were performed using Bonferroni correction (as the results were not 
all obtained at the same time). When analysing the triple stained acute rejection biopsies; the 
spread of data and proximity to zero of a significant proportion of the data (skewing of distribution) 
prevented the data being considered as normally distributed. Therefore the Kruskall-Wallis non-
parametric test was employed as an alternative to a one-way ANOVA. 
 
Supplementary figure 1: Expression of CK19 and E-Cadherin antigens by H69 biliary epithelial cells. 
For both antigens confocal microscopy images are present from control and 48 and 72 hours post 
hydrogen peroxide exposure; alongside densitometric analysis. Panels A-D show CK19 expression, 
this is significant at p = 0.0273. Panels E-H show E-Cadherin expression, significant at p = 0.039. 
Supplementary figure 2: Hydrogen peroxide induced the expression of beta6 integrin on H69 cells. 
To ascertain what may be causing the activation of TGF-beta within the H69 treated cells, staining 
for beta6 containing integrins was performed. This showed a significant up regulation at 48 hours 
post peroxide exposure  
Supplementary Figure 3: Autofluorescence of ACR biopsies. There is clear evidence of lipofuscin 
granules (white arrows) presence within BEC and hepatocytes, enhancing the data demonstrating 
senescence marker expression within these cells.  
 
Page 60 of 64
ScholarOne support: (434) 964 4100
American Journal of Transplantation
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
IN SUBMISSION
 
 
 
 
Page 61 of 64
ScholarOne support: (434) 964 4100
American Journal of Transplantation
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
IN SUBMISSION
       0 Hours             48 Hours          72 Hours   
CK19
A
v
e
ra
g
e
 P
ix
e
l 
In
te
n
s
it
y
C
on
tr
ol
48
 H
ou
rs
72
 H
ou
rs
0
50
100
150
E-Cadherin
A
v
e
ra
g
e
 P
ix
e
l 
In
te
n
s
it
y
C
on
tr
ol
48
 H
ou
rs
72
 H
ou
rs
0
50
100
150
       0 Hours             48 Hours          72 Hours   
A B C D 
E F G H 
Supplementary figure 1 
Page 62 of 64
ScholarOne support: (434) 964 4100
American Journal of Transplantation
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
IN SUBMISSION
 0 Hours                      48 Hours                   
Supplementary figure 2 Page 63 of 64
ScholarOne support: (434) 964 4100
American Journal of Transplantation
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
IN SUBMISSION
Supplementary figure 3 Page 64 of 64
ScholarOne support: (434) 964 4100
American Journal of Transplantation
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
